RxDoctor Payments Data

Terri Duncan

Family · Kingsport, TNNPI 1750501326

Payments from drug & device makers

$11,722in general payments, 2019–2025

Across 656 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$2K
  • AstraZeneca$941
  • Bayer$818
  • Lilly USA, LLC$776
  • GSK$641
  • plus $5K from 36 others

What the payments were for

  • Food & beverage$11,690100%
  • Education$320%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,722 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$75,721
Medicare patients
152
Services billed
1,330

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide93$141,379
OzempicSemaglutide92$127,239
EliquisApixaban101$107,362
JardianceEmpagliflozin77$85,379
CreonLipase/Protease/Amylase23$76,417
Trelegy ElliptaFluticasone/Umeclidin/Vilanter63$58,440
Tresiba Flextouch U-200Insulin Degludec63$51,077
XareltoRivaroxaban36$48,262
FarxigaDapagliflozin Propanediol36$38,420
JanuviaSitagliptin Phosphate34$37,260
MyrbetriqMirabegron34$33,700
UbrelvyUbrogepant29$31,199
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog32$29,855
Breztri AerosphereBudesonide/Glycopyr/Formoterol35$28,067
BelsomraSuvorexant60$25,852

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$776$165,150104 claims
AbbVieCreon, Ubrelvy, Vraylar, Linzess$1,627$154,95496 claims
Novo NordiskOzempic$2,240$127,23992 claims
PfizerEliquis, Premarin$442$114,350115 claims
Boehringer IngelheimJardiance, Stiolto Respimat$241$95,57693 claims
GSKTrelegy Ellipta, Breo Ellipta$641$79,20198 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$941$78,330110 claims
MerckJanuvia, Belsomra, Janumet$181$73,213105 claims
Johnson & JohnsonXarelto$207$48,26236 claims
Astellas Pharma US IncMyrbetriq$19$33,70034 claims
AmgenProlia$596$22,51013 claims
BayerKerendia$818$18,67417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,706 family providers in Tennessee.

Other family in Kingsport

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →